Summary. Intravaginal rings containing progesterone were inserted on Day 5 of the cycle to 8 healthy, normally menstruating women. Blood samples were taken during Days 4\p=n-\22of the cycle at 2\p=n-\3-day intervals.
Introduction
The role of progesterone in regulating human follicular function is not fully understood. Hoffman (1962) postulated that progesterone is responsible for suppressing follicular growth during the luteal phase in the normal menstrual cycle. Experiments by Goodman & Hodgen (1977) on rhesus monkeys, and observations of Leyendecker, Wildt, Gips, Noche & Plotz (1976) on women, indicate that progesterone might have an inhibitory effect on follicular function. The synthetic gestagen, medroxyprogesterone, administered via intravaginal rings, has also been shown to inhibit follicular development as indicated by plasma oestradiol levels (Thiery, Vandekerckhove, Dhont, Vermeulen & Decoster, 1976) . Bendz (1977) demonstrated that there is an anatomical basis for a countercurrent exchange between utero-ovarian veins and ovarian arteries in the human adnexa. Transfer of krypton-85 from the uterine vein to the ovarian artery of women has been shown (Bendz, Einer-Jensen, Lundgren & Janson, 1979). Progesterone, but not bovine serum albumin, is transferred from the uterine vein to the ovarian artery of ewes (McCracken & Einer-Jensen, 1976 6, 7, 9, 11, 13, 16, 19 and 22 Carstensen & Bäckström (1976) . In the present study, however, the paper Chromatographie step used in the original procedure was omitted. The figures given below refer to these later variants.
For the determination of oestradiol-17 ß, an antiserum to oestradiol-17 ß-6 (Ocarboxymethyl) oxime-bovine serum albumin was used (prepared by Dr H. R. Lindner, Weizman Institute, Rehovot, Israel). No significant difference was found between 10 different plasma samples analysed with and without paper chromatography (414 ± 396 and 407 ± 396 pmol oestradiol/1 respectively). The coefficient of variation between these methods was 13-3% and the coefficient of correlation r = 0-99. The within-assay variation for the nonchromatographic method was 10% at oestradiol values below 370 pmol/1 (n = 100) and 7% at oestradiol values above that level (n = 132). The (Feldman & Rodbard, 1971 ).
Statistical methods
Differences between groups were tested by the Mann-Whitney U-test and differences within groups by Wilcoxon's paired rank sign test (Siegel, 1956 ). The follicular-phase FSH levels of the treated subjects and the controls were tested by one-factor analysis of variance (Wonnacott & Wonnacott, 1972 (Text-fig. 1 ). In the 4 women showing an oestradiol rise the mean plasma progesterone level on the day of insertion was 9-2 nmol/1 and increased up to 11 nmol/1 the day after insertion. The mean level on Day 13 of the cycle was 8-4 nmol/1. Three of these subjects had a late rise in plasma progesterone up to 36, 37 and 62 nmol/1, indicating the presence of a corpus luteum. The mean plasma progesterone concentrations of Days 5-13 were significantly lower in the ovulatory subjects compared to the anovulatory subjects (9-8 and 11-8 nmol/1; ANOVA, F = 6-40, < 0-05). The FSH levels of the treated women were significantly higher than those of the controls between Days 6 and 13 (one-factor analysis of variance: F = 16-4, < 0-0005 for the anovulatory subjects and F = 24-6, < 0-0005 for the whole group, 8 women). The time between Days 6 and 13 was chosen because Day 6 was the day after ring insertion, and Day 13 was before the gonadotrophin surge that occurred in the controls (Text-fig. 1 ).
The mean LH levels were all within the range of the controls except for Days 19 and 22 of the anovulatory subjects (Text- fig. 1 ). These mean levels were significantly increased compared to those of the controls (P < 0-006 and 0-014, respectively). No LH peaks were recorded in the ovulatory subjects, probably because of the intervals between the blood samples. One subject showed an LH peak value of 78 units/1 on Day 22 and also showed a preceding peak in plasma oestradiol. However, no significant increase in plasma progesterone was observed for this subject.
The mean plasma prolactin levels of the anovulatory subjects or the whole experimental group were not significantly different from the mean control values.
Discussion
The results from the (Fukuda, Katayama & Tojo, 1980) , rhesus monkeys (Goodman & Hodgen, 1977) and women after vaginally administered medroxyprogesterone (Thiery et al, 1976) . A progesterone cytoplasmic receptor has also been shown to be present in the human ovary (Jacobs, Suchocki & Smith, 1980) . The reason why not all of the subjects were anovulatory might be that the release of progesterone from the intravaginal ring was quite small. The plasma levels achieved correspond, in the early part of the experiment, with early luteal-phase levels. However, the progesterone concentration in the later part of the experiment was even lower and corresponds to preovulatory levels.
Our hypothesis is that progesterone inhibited oestradiol production locally in the ovary, but the concentration of progesterone achieved in the ovary was probably at the border line of its action and because of individual sensitivity and perhaps lower vaginal résorption of progesterone in the subjects with ovulation, oestradiol production was not inhibited in all subjects. This is supported by the findings of a higher ovulation rate in two similar studies using progesteronereleasing intravaginal rings, but with an even lower plasma progesterone level (Victor, Jackanicz & Johansson, 1978; Toivonen, 1981 
